Vicente Bohorquez-Merino

Pharmacokinetic/pharmacodynamic optimization of temocillin treatment against CTX-M-15-producing Klebsiella pneumoniae isolates in a hollow-fiber infection model.

Journal: Antimicrobial agents and chemotherapy

Published: November 12, 2025

Therapeutic drug monitoring of a posaconazole-cyclosporine interaction in a patient with bone marrow aplasia: A case report.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: August 30, 2025

Real-life outcomes of benralizumab treatment in chronic rhinosinusitis with nasal polyps: The BenREALizumab study.

Journal: Acta otorrinolaringologica espanola

Published: August 13, 2025

Persistence of optimal and suboptimal response in chronic immune-mediated inflammatory diseases.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: July 24, 2025

[Translated article] Persistence of optimal and suboptimal response in chronic immune-mediated inflammatory diseases.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: July 24, 2025

Hepatic Safety of Adjunctive High-Dose Melatonin in Participants Receiving Ocrelizumab for Primary Progressive Multiple Sclerosis: Liver Toxicity Findings from a Phase I/II Randomised Clinical Trial (MELATOMS-1).

Journal: CNS drugs

Published: July 17, 2025

Critical role of persistence and adherence in multiple sclerosis treatment: the value of cladribine.

Journal: European journal of hospital pharmacy : science and practice

Published: July 02, 2025

Vedolizumab trough concentrations and clinical outcomes in patients with Crohn's disease: a real-world observational study comparing intravenous and subcutaneous administration.

Journal: European journal of hospital pharmacy : science and practice

Published: May 28, 2025

Usefulness of therapeutic drug monitoring of vedolizumab in the control of response in Crohn's disease.

Journal: Medicina clinica

Published: May 01, 2025

Defining partial response in inflammatory bowel disease: a Delphi consensus and economic evaluation.

Journal: Therapeutic advances in gastroenterology

Published: April 09, 2025

Journal: Open respiratory archives

Published: December 24, 2024

Effectiveness and tolerability of intravenous fosfomycin in treating complicated urinary tract infections caused by Escherichia coli: a prospective cohort study from the FOSFOMIC project.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: September 23, 2024

Pharmacokinetic/pharmacodynamic optimization of temocillin treatment against CTX-M-15-producing Klebsiella pneumoniae isolates in a hollow-fiber infection model.

Pharmacokinetic/pharmacodynamic optimization of temocillin treatment against CTX-M-15-producing Klebsiella pneumoniae isolates in a hollow-fiber infection model.

Therapeutic drug monitoring of a posaconazole-cyclosporine interaction in a patient with bone marrow aplasia: A case report.

Therapeutic drug monitoring of a posaconazole-cyclosporine interaction in a patient with bone marrow aplasia: A case report.

Real-life outcomes of benralizumab treatment in chronic rhinosinusitis with nasal polyps: The BenREALizumab study.

Real-life outcomes of benralizumab treatment in chronic rhinosinusitis with nasal polyps: The BenREALizumab study.

Persistence of optimal and suboptimal response in chronic immune-mediated inflammatory diseases.

Persistence of optimal and suboptimal response in chronic immune-mediated inflammatory diseases.

[Translated article] Persistence of optimal and suboptimal response in chronic immune-mediated inflammatory diseases.

[Translated article] Persistence of optimal and suboptimal response in chronic immune-mediated inflammatory diseases.

Hepatic Safety of Adjunctive High-Dose Melatonin in Participants Receiving Ocrelizumab for Primary Progressive Multiple Sclerosis: Liver Toxicity Findings from a Phase I/II Randomised Clinical Trial (MELATOMS-1).

Hepatic Safety of Adjunctive High-Dose Melatonin in Participants Receiving Ocrelizumab for Primary Progressive Multiple Sclerosis: Liver Toxicity Findings from a Phase I/II Randomised Clinical Trial (MELATOMS-1).

Critical role of persistence and adherence in multiple sclerosis treatment: the value of cladribine.

Critical role of persistence and adherence in multiple sclerosis treatment: the value of cladribine.

Vedolizumab trough concentrations and clinical outcomes in patients with Crohn's disease: a real-world observational study comparing intravenous and subcutaneous administration.

Vedolizumab trough concentrations and clinical outcomes in patients with Crohn's disease: a real-world observational study comparing intravenous and subcutaneous administration.

Usefulness of therapeutic drug monitoring of vedolizumab in the control of response in Crohn's disease.

Usefulness of therapeutic drug monitoring of vedolizumab in the control of response in Crohn's disease.

Defining partial response in inflammatory bowel disease: a Delphi consensus and economic evaluation.

Defining partial response in inflammatory bowel disease: a Delphi consensus and economic evaluation.

BioCart© Opinion-based Study on Home Administration Support for Biological Therapies in Patients with Severe Asthma.

BioCart© Opinion-based Study on Home Administration Support for Biological Therapies in Patients with Severe Asthma.

Effectiveness and tolerability of intravenous fosfomycin in treating complicated urinary tract infections caused by Escherichia coli: a prospective cohort study from the FOSFOMIC project.

Effectiveness and tolerability of intravenous fosfomycin in treating complicated urinary tract infections caused by Escherichia coli: a prospective cohort study from the FOSFOMIC project.